ExplorerAI in Drug DiscoveryAI
Research PaperResearchia:202607.14048

Advancing Optimal Subset Oracle via Learning Relaxation of Neural Set Functions

Yongquan Shi

Abstract

Learning neural set functions is pivotal to a wide range of important applications, including compound selection in AI-driven drug discovery and product recommendation. Recent work has introduced optimal subset oracles to implicitly learn set functions under practical weakly supervised settings, where model parameters are optimized through mean-field variational inference. However, these frameworks rely on Monte Carlo sampling to estimate gradients of the evidence lower bound when updating the v...

Submitted: July 14, 2026Subjects: AI; AI in Drug Discovery

Description / Details

Learning neural set functions is pivotal to a wide range of important applications, including compound selection in AI-driven drug discovery and product recommendation. Recent work has introduced optimal subset oracles to implicitly learn set functions under practical weakly supervised settings, where model parameters are optimized through mean-field variational inference. However, these frameworks rely on Monte Carlo sampling to estimate gradients of the evidence lower bound when updating the variational distribution. Repeated sampling across iterations incurs substantial computational overhead, while the resulting stochasticity can destabilize the optimization trajectory. In this work, we reinterpret the evidence lower bound as a continuous relaxation of the set function and learn a surrogate objective that replaces sampling-based ELBO gradient estimation during variational optimization. The learned surrogate provides stable and efficient gradients throughout the continuous domain, thereby reducing computational overhead and accelerating inference. Furthermore, we establish an approximation guarantee for the proposed framework under submodular maximization and characterize its connection to variational free energy. Experiments on a variety of real-world tasks demonstrate consistent improvements over existing baselines.


Source: arXiv:2607.11555v1 - http://arxiv.org/abs/2607.11555v1 PDF: https://arxiv.org/pdf/2607.11555v1 Original Link: http://arxiv.org/abs/2607.11555v1

Please sign in to join the discussion.

No comments yet. Be the first to share your thoughts!

Access Paper
View Source PDF
Submission Info
Date:
Jul 14, 2026
Topic:
AI in Drug Discovery
Area:
AI
Comments:
0
Bookmark
Advancing Optimal Subset Oracle via Learning Relaxation of Neural Set Functions | Researchia